Results
|
9501.
|
Pharmacological modulation of humoral immunity in a nonhuman primate model of AAV gene transfer for hemophilia B. [electronic resource] by
- Mingozzi, Federico
- Chen, Yifeng
- Murphy, Samuel L
- Edmonson, Shyrie C
- Tai, Alex
- Price, Sandra D
- Metzger, Mark E
- Zhou, Shangzhen
- Wright, J Fraser
- Donahue, Robert E
- Dunbar, Cynthia E
- High, Katherine A
Producer: 20130116
In:
Molecular therapy : the journal of the American Society of Gene Therapy vol. 20
Availability: No items available.
|
|
9502.
|
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care. [electronic resource] by
- Vassilakopoulos, Theodoros P
- Pangalis, Gerassimos A
- Katsigiannis, Andreas
- Papageorgiou, Sotirios G
- Constantinou, Nikos
- Terpos, Evangelos
- Zorbala, Alexandra
- Vrakidou, Effimia
- Repoussis, Panagiotis
- Poziopoulos, Christos
- Galani, Zacharoula
- Dimopoulou, Maria N
- Kokoris, Stella I
- Sachanas, Sotirios
- Kalpadakis, Christina
- Dimitriadou, Evagelia M
- Siakantaris, Marina P
- Kyrtsonis, Marie-Christine
- Dervenoulas, John
- Dimopoulos, Meletios A
- Meletis, John
- Roussou, Paraskevi
- Panayiotidis, Panayiotis
- Beris, Photis
- Angelopoulou, Maria K
Producer: 20120625
In:
The oncologist vol. 17
Availability: No items available.
|
|
9503.
|
|
|
9504.
|
Phase II trial of rituximab plus CVP combination chemotherapy for advanced stage marginal zone lymphoma as a first-line therapy: Consortium for Improving Survival of Lymphoma (CISL) study. [electronic resource] by
- Kang, Hye Jin
- Kim, Won Seog
- Kim, Seok Jin
- Lee, Je-Jung
- Yang, Deok-Hwan
- Kim, Jin Seok
- Lee, Se-Ryeon
- Lee, Gyeong-Won
- Kim, Hyo Jung
- Kim, Ho Young
- Oh, Sung Yong
- Kim, Hugh Chul
- Eom, Hyeon-Seok
- Chung, Jooseop
- Park, Jinny
- Suh, Cheolwon
- Ryoo, Baek-Yeol
Producer: 20120510
In:
Annals of hematology vol. 91
Availability: No items available.
|
|
9505.
|
|
|
9506.
|
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by ⁹⁰Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma. [electronic resource] by
- Zinzani, P L
- Tani, M
- Pulsoni, A
- De Renzo, A
- Stefoni, V
- Broccoli, A
- Montini, G C
- Fina, M
- Pellegrini, C
- Gandolfi, L
- Cavalieri, E
- Torelli, F
- Scopinaro, F
- Argnani, L
- Quirini, F
- Derenzini, E
- Rossi, M
- Pileri, S
- Fanti, S
- Baccarani, M
Producer: 20120522
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 23
Availability: No items available.
|
|
9507.
|
|
|
9508.
|
|
|
9509.
|
|
|
9510.
|
|
|
9511.
|
|
|
9512.
|
|
|
9513.
|
Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein neuropathy. [electronic resource] by
- Léger, Jean-Marc
- Viala, Karine
- Nicolas, Guillaume
- Créange, Alain
- Vallat, Jean-Michel
- Pouget, Jean
- Clavelou, Pierre
- Vial, Christophe
- Steck, Andreas
- Musset, Lucile
- Marin, Benoit
Producer: 20130814
In:
Neurology vol. 80
Availability: No items available.
|
|
9514.
|
|
|
9515.
|
|
|
9516.
|
|
|
9517.
|
|
|
9518.
|
|
|
9519.
|
|
|
9520.
|
|